Cancer Survival Current Events | Cancer Survival News | 9
|
| Page
9 of
124 |
2464 Results |
|
|
|
Sort By:
Page Views | Date |
New results help predict treatment response in colorectal cancer
Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, late breaking results show. view more (2008-09-17)
Study examines factors associated with survival in advanced laryngeal cancer
Type of treatment, sex, race and insurance status are associated with survival rates among patients with advanced laryngeal cancer, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. view more (2007-12-18)
Novel 4-drug combination proves safe for lung cancer treatment
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center. view more (2008-11-13)
Androgen deprivation therapy does not keep localized prostate cancer from spreading, new study says
Oregon Health & Science University Cancer Institute researchers wanted to know if depriving men of testosterone actually keeps cancer from spreading beyond the prostate. view more (2006-02-27)
A potential sugar fix for tumors
Researchers at the Duke School of Medicine apparently have solved the riddle of why cancer cells like sugar so much, and it may be a mechanism that could lead to better cancer treatments. view more (2008-04-16)
Study drug holds promise as alternative to castration for early prostate cancers
For those unwilling to undergo chemical castration however, results of an international study led by a Medical College of Wisconsin researcher show promise for an oral drug as an alternative. view more (2006-08-23)
Pre-treatment blood test could guide lung cancer therapy
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has discovered a "signature" of proteins in the blood that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies. view more (2007-06-06)
No differences in survival or neonatal outcomes in pregnancy-associated colorectal cancer
In one of the first studies to examine maternal and newborn health risks and colorectal cancer, UC Davis researchers have found that women diagnosed with the disease during or shortly after their pregnancies have the same survival as women who have the disease and are not pregnant. view more (2009-02-27)
More women with early-stage breast cancer choosing double mastectomies
A University of Minnesota cancer surgeon and researcher has found a dramatic increase in the number of women diagnosed with the earliest stage of breast cancer choosing to have both breasts surgically removed. view more (2009-04-10)
Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
A new study has shown for the first time that giving two chemotherapy drugs to women with advanced endometrial cancer after surgery reduced the risk of recurrence by 29% and extended survival by 32% compared with women who received whole abdominal irradiation. view more (2005-12-06)
Honey-bee products in cancer treatment and prevention
Natural honey-bee products such as propolis, royal jelly, caffeic acid, honey and venom may have applications in cancer treatment and prevention, say Croatian researchers in Journal of the Science of Food and Agriculture this month. view more (2004-12-02)
KEAP1 Keeps major cancer-promoting protein at bay
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports this week in the journal Molecular Cell. view more (2009-10-12)
Whole-brain radiotherapy after surgery or radiosurgery not recommended for brain metastases
Whole-brain radiotherapy should not be given routinely to all patients whose cancer has spread to the brain, say researchers who found that using it after surgery or radiosurgery in patients with a limited number of brain metastases and stable cancer in the rest of the body did not extend lives or help patients remain functionally independent for... view more... (2009-09-22)
Early disclosure: post-operative radiotherapy improves progression-free survival in prostate cancer
Immediate post-operative radiotherapy following surgery to remove the prostate results in improved progression-free survival for prostate cancer patients, according to the results of a study presented here today (Tuesday 26th October 2004) by Prof Michel Bolla of CHU de Grenoble, Grenoble, France, at the 23rd Meeting of the European Society for... view more... (2004-10-26)
Counting tumor cells in blood predicts treatment benefit in prostate cancer
Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. view more (2008-07-07)
New developments in biomarkers for epithelial ovarian cancer
With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer. view more (2007-11-30)
M. D. Anderson study finds dramatic increase in metastatic colon cancer survival
Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease. view more (2009-05-27)
Cancer conflict with chemotherapy treatment
Women under the age of forty with breast cancer who are given drugs in addition to lumpectomies or radiotherapy, known as adjuvant chemotherapy, may not be benefiting from these drugs. view more (2007-10-11)
European trial finds old lung cancer treatment may still be best
The first clinical trial to compare directly two of the most widely-used drugs in advanced lung cancer, cisplatinin and carboplatin (both in combination with paclitaxel) - have concluded that the older drug, cisplatin, is the better treatment. Patients given cisplatin and paclitaxel had better survival rates and their quality of life was just as... view more... (2002-10-07)
Improving the management of head and neck cancers
Cancers of the head and neck cause over 2,700 deaths per year in England and Wales. Smoking and drinking cause most cancers of the mouth, lip and tongue (oral cavity), throat and voice box. Heavy drinkers who are also heavy smokers have over 35 times the risk of developing oral cancer than non-smokers and drinkers. Early detection and appropriate... view more... (2004-11-22)
|
|
| Page
9 of
124 |
2464 Results |
|
|
|
Sort By:
Page Views | Date |
|
